OPKO Health has been a very poor performer in my portfolio. The company has had a lot of ups and downs over the last few years. It has taken a new go-to-market strategy as of late. It has license ...

OPK and PFE received FDA approval for Ngenla in June. This enables OPK to receive royalties going forward. OPK has continued to lose money due to its lab business. The business had sales fall off ...

OPKO Health Inc.’s OPK BioReference Laboratories, Inc. recently announced that it has started accepting specimens for a new multiplex COVID-19 and influenza test, which can be utilized by healthcare ...

OPKO Health Inc.’s OPK company — BioReference Laboratories — recently made an announcement regarding its COVID-19 testing preparedness in the face of the Omicron Variant. In fact, BioReference’s PCR ...

Having college and professional athletes play sports during a pandemic can create logistics problems with social distancing and COVID-19 testing. Two small cap companies have won contracts to help ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...

Each year, there are around 200,000 distinct insider transactions reported to SEC via Form 4 filings. While the term “insider trading” sounds nefarious, there are just a handful of cases deemed ...